Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)

被引:0
|
作者
Jeroen J. A. van Kampen
David A. M. C. van de Vijver
Pieter L. A. Fraaij
Bart L. Haagmans
Mart M. Lamers
Nisreen Okba
Johannes P. C. van den Akker
Henrik Endeman
Diederik A. M. P. J. Gommers
Jan J. Cornelissen
Rogier A. S. Hoek
Menno M. van der Eerden
Dennis A. Hesselink
Herold J. Metselaar
Annelies Verbon
Jurriaan E. M. de Steenwinkel
Georgina I. Aron
Eric C. M. van Gorp
Sander van Boheemen
Jolanda C. Voermans
Charles A. B. Boucher
Richard Molenkamp
Marion P. G. Koopmans
Corine Geurtsvankessel
Annemiek A. van der Eijk
机构
[1] Erasmus MC,Department of Viroscience
[2] Subdivision Infectious Diseases and Immunology,Department of Pediatrics
[3] Erasmus MC - Sophia,Department of Intensive Care
[4] Erasmus MC,Department of Hematology
[5] Erasmus MC,Department of Pulmonary Medicine
[6] Erasmus MC,Department of Internal Medicine, Division of Nephrology and Transplantation
[7] Erasmus MC Transplant Institute,Department of Gastroenterology and Hepatology
[8] Erasmus MC,Department of Medical Microbiology and Infectious Diseases
[9] Erasmus MC,undefined
[10] Erasmus MC,undefined
来源
Nature Communications | / 12卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Key questions in COVID-19 are the duration and determinants of infectious virus shedding. Here, we report that infectious virus shedding is detected by virus cultures in 23 of the 129 patients (17.8%) hospitalized with COVID-19. The median duration of shedding infectious virus is 8 days post onset of symptoms (IQR 5–11) and drops below 5% after 15.2 days post onset of symptoms (95% confidence interval (CI) 13.4–17.2). Multivariate analyses identify viral loads above 7 log10 RNA copies/mL (odds ratio [OR] of 14.7 (CI 3.57-58.1; p < 0.001) as independently associated with isolation of infectious SARS-CoV-2 from the respiratory tract. A serum neutralizing antibody titre of at least 1:20 (OR of 0.01 (CI 0.003-0.08; p < 0.001) is independently associated with non-infectious SARS-CoV-2. We conclude that quantitative viral RNA load assays and serological assays could be used in test-based strategies to discontinue or de-escalate infection prevention and control precautions.
引用
收藏
相关论文
共 50 条
  • [41] Symptoms of Dry Eye Disease in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19)
    Wang, Yan
    Yang, Sen
    Zhang, Yue
    Zhang, Xin
    Jiang, Yaping
    Wang, Xixi
    Zheng, Pengxiang
    Chen, Yihui
    JOURNAL OF OPHTHALMOLOGY, 2021, 2021
  • [42] Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (COVID-19) Patients
    Seah, Ivan Yu Jun
    Anderson, Danielle E.
    Kang, Adrian Eng Zheng
    Wang, Linfa
    Rao, Pooja
    Young, Barnaby Edward
    Lye, David Chien
    Agrawal, Rupesh
    OPHTHALMOLOGY, 2020, 127 (07) : 977 - 979
  • [43] Cardiac involvement in patients recovered from coronavirus disease-2019 (COVID-19): a systematic review
    Shafiabadi, N.
    Rastad, H.
    Mozafarybazargany, M.
    Talakoob, H.
    Karim, H.
    EUROPEAN HEART JOURNAL, 2021, 42 : 234 - 234
  • [44] Recovery from the coronavirus disease-2019 (COVID-19) in two patients with coexisted (HIV) infection
    Wu, Qiuji
    Chen, Tielong
    Zhang, Hongyan
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (11) : 2325 - 2327
  • [45] Provider Satisfaction With Infectious Diseases Telemedicine Consults for Hospitalized Patients During the Coronavirus Disease 2019 (COVID-19) Pandemic
    Canterino, Joseph E.
    Wang, Kaicheng
    Golden, Marjorie
    CLINICAL INFECTIOUS DISEASES, 2022, 74 (04) : 711 - 714
  • [46] Advanced bioinformatics rapidly identifies existing therapeutics for patients with coronavirus disease-2019 (COVID-19)
    Jason Kim
    Jenny Zhang
    Yoonjeong Cha
    Sarah Kolitz
    Jason Funt
    Renan Escalante Chong
    Scott Barrett
    Rebecca Kusko
    Ben Zeskind
    Howard Kaufman
    Journal of Translational Medicine, 18
  • [47] Advanced bioinformatics rapidly identifies existing therapeutics for patients with coronavirus disease-2019 (COVID-19)
    Kim, Jason
    Zhang, Jenny
    Cha, Yoonjeong
    Kolitz, Sarah
    Funt, Jason
    Escalante Chong, Renan
    Barrett, Scott
    Kusko, Rebecca
    Zeskind, Ben
    Kaufman, Howard
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [48] Pulmonary Function Tests in Patients Post-Infection by Coronavirus Disease-2019 (COVID-19)
    Yaqoob, H.
    Manglani, R. P.
    Mathew, J.
    Fenster, M.
    Schluger, N. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [49] Novel coronavirus disease-2019 (COVID-19) in people with rheumatic disease: Epidemiology and outcomes
    Grainger, Rebecca
    Machado, Pedro M.
    Robinson, Philip C.
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2021, 35 (01):
  • [50] Nursing and Care Practice Strategies in the Coronavirus Disease-2019 (COVID-19) Pandemic
    Tosun, Hale
    Sumer Dalkiran, Seda
    BEZMIALEM SCIENCE, 2022, 10 (02): : 238 - 241